A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer. - Jatoi A; Foster NR; Wahner Hendrickson A; Block MS; Weroha SJ; Asmus EJ; Murray NR; Fields AP (American journal of clinical oncology, 2026)